Search for information about a product,
therapeutic area or event

Search

Media, investors, advocacy organizations and others, please contact us here.

Posters

Association Between Homocysteine and Clinical Outcomes in Patients With Classical Homocystinuria: A Systematic Literature Review

Learn More
Posters

Clinical Burden of Classical Homocystinuria in the United States: A Retrospective Claims Analysis

Learn More
Posters

Economic Burden of Classical Homocystinuria in the United States

Learn More
Posters

Matching-Adjusted Indirect Comparisons of eGFR slopes in the PROTECT study with UK RaDaR IgA Nephropathy population and the control arm of NefIgArd

Learn More
Posters

 The Humanistic Burden of Rare Kidney Diseases: Understanding the Impact of Immunoglobulin A Nephropathy (IgAN) and Focal Segmental Glomerulosclerosis (FSGS) on Patients and Care-Partners Study (HONUS): Results for IgAN and FSGS in Europe

Learn More
Posters

Sparsentan Has Direct Effects on the Glomerular Capillary Wall to Attentuate Increased Permeability After Exposure to Nephrotic Syndrome Plasma

Learn More
Posters

Natural History of Idiopathic Nephrotic Syndrome: The UK National RaDaR Idiopathic Nephrotic Syndrome Cohort

Learn More
Posters

Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Patients With IgA Nephropathy (IgAN) in the PROTECT Open-Label Extension (OLE)

Learn More
Posters

The Humanistic Burden of Rare Kidney Diseases: Understanding the Impact of Immunoglobulin A Nephropathy (IgAN) and Focal Segmental Glomerulosclerosis (FSGS) on Patients and Care-Partners Study (HONUS): Results for IgAN and FSGS in Europe

Learn More
Posters

Sparsentan Has Direct Effects on the Glomerular Capillary Wall to Attenuate Increased Permeability After Exposure to Nephrotic Syndrome Plasma

Learn More
Posters

PROTECT and NefIgArd 2-Year Proteinuria and eGFR Outcomes in Adults with IgA Nephropathy: Matching-Adjusted Indirect Comparison (MAIC)

Learn More
Posters

Matching-Adjusted Indirect Comparisons of eGFR Slopes in the PROTECT study with UK RaDaR IgA Nephropathy Population and the Control Arm of NefIgArd

Learn More
Posters

Natural History of Idiopathic Nephrotic Syndrome: The UK National RaDaR Idiopathic Nephrotic Syndrome Cohort Presentation

Learn More